FDA Warns About Dangers Of ‘Natural’ Opioid Kratom
Enlarge this photograph toggle caption Joe Raedle/Getty Pictures Joe Raedle/Getty Images
Federal government health officials Tuesday issued a warning about kratom, a organic product being promoted as a secure alternative to opioids for pain that is also marketed for treating addiction, anxiety and depression.
The Food and Drug Administration says there’s insufficient evidence the supplement works to treat habit or other problems, and cited growing evidence it might be dangerous. Kratom could cause seizures, liver damage and withdrawal symptoms.
“It is rather troubling to the FDA that people believe they are able to use kratom to treat opioid withdrawal symptoms,” FDA commissioner Scott Gottlieb said in a assertion, adding that not only is there no trustworthy evidence that kratom is an effective treatment for opioid make use of disorder, there are FDA-approved medications that work.
Phone calls to U.S. poison control centers about kratom, which is manufactured out of a plant that grows in Asia, jumped tenfold from 2010 to 2015, based on the FDA. At least 36 deaths are associated with the use of items containing kratom, the firm says.
“I understand that there surely is a lot of curiosity in the likelihood for kratom to be used as a potential remedy for a variety of disorders,” Gottlieb added. “But the FDA has a science-structured obligation that supersedes common trends and depends on evidence.”
Due to this fact, the agency has begun seizing items of kratom and taking guidelines to prevent future shipments from being imported in to the United States, the FDA says.
Attempts to restrict kratom possess sparked a backlash from advocates of the supplement’s use. This past year, the Drug Enforcement Administration stepped back again from taking action pending a review the FDA. The FDA says that assessment is underway.